What are the recommended treatments for facial psoriasis?

Treatment of Facial Psoriasis

For facial psoriasis, use calcipotriene combined with low-potency hydrocortisone for 8 weeks as first-line therapy, or alternatively use tacrolimus 0.1% ointment for up to 8 weeks. 1

Primary Treatment Approach

The 2021 Joint AAD-NPF Guidelines provide clear direction for facial psoriasis management, which differs from body psoriasis due to the thinner, more sensitive facial skin:

First-Line Options (Choose One):

Option 1: Calcipotriene + Hydrocortisone Combination

• Apply calcipotriene (vitamin D analogue) combined with hydrocortisone 10 mg/g for 8 weeks
• This combination demonstrated superior facial efficacy compared to calcipotriene alone (odds ratio 2.01, P = 0.001) in achieving clear or almost clear skin 1
• The hydrocortisone component is specifically low-potency to minimize atrophy risk on facial skin
• Strength of recommendation: B 1

Option 2: Tacrolimus 0.1% Ointment

• Apply twice daily for up to 8 weeks
• In RCTs, 65% of patients achieved clear or almost clear status versus 31% with placebo 1
• Particularly valuable as a steroid-sparing agent for prolonged use
• Strength of recommendation: B 1
• Effective response demonstrated in 90.5% of patients (complete or good response) 2

Option 3: Tacalcitol Ointment

• Another vitamin D analogue option for facial psoriasis
• Can be combined with hydrocortisone similar to calcipotriene 1

Critical Facial-Specific Considerations

Why facial psoriasis requires different treatment:

• Face and intertriginous areas are at highest risk for corticosteroid-induced atrophy, striae, and telangiectasia 1
• Avoid potent or ultrapotent corticosteroids on the face - these are appropriate for body psoriasis but too strong for facial skin
• Use only low-potency corticosteroids (like hydrocortisone) when steroids are needed on the face

Common Pitfalls to Avoid

1. Do not use salicylic acid simultaneously with calcipotriene - the acidic pH inactivates calcipotriene and reduces effectiveness 1

2. Avoid abrupt corticosteroid withdrawal - can cause rebound flare; taper frequency gradually after clinical improvement 1

3. Counsel patients about tacrolimus burning - burning and pruritus are common initially but improve with continued use; can be mitigated by avoiding application to moist skin 1

4. Do not apply vitamin D analogues before phototherapy - UVA radiation decreases calcipotriene concentration; apply after phototherapy if combining treatments 1

When First-Line Therapy Fails

If topical therapy does not achieve satisfactory results after 8 weeks:

• Consider adding phototherapy (though facial psoriasis shows variable UV response) 3
• Escalate to systemic therapy for moderate-to-severe disease 4
• Topical calcineurin inhibitors can be used long-term as steroid-sparing maintenance 5, 6

Alternative Agents (Lower Priority)

Pimecrolimus cream can be considered for facial psoriasis, though tacrolimus has stronger evidence 1

Calcitriol ointment is another vitamin D analogue option, though less commonly used than calcipotriene 1

Practical Application Strategy

1. Start with calcipotriene + hydrocortisone combination if patient has no prior steroid concerns
2. Start with tacrolimus 0.1% if patient has history of steroid-induced atrophy or requires long-term maintenance therapy
3. Apply twice daily for 8 weeks, then reassess
4. Set realistic expectations - vitamin D analogues show efficacy at 8 weeks but not at 4 weeks 1

The evidence strongly supports these facial-specific approaches over simply using body psoriasis treatments on the face, which carries unacceptable risk of permanent skin damage.